Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment consists of products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment involves the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Frequently Asked Questions
What is market cap of Hologic, Inc.?
The market cap of Hologic, Inc. is $19.36B
What is the 52 week high for Hologic, Inc.?
The 52 week high for Hologic, Inc. is $86.65.
What is the 52 week low for Hologic, Inc.?
The 52 week low for Hologic, Inc. is $59.78.
What is Hologic, Inc. stock price today?
Hologic, Inc.' stock price today is $78.84.
What is the pe ratio of Hologic, Inc.?
The PE ratio of Hologic, Inc. is 20.03.
What is the price to book ratio of Hologic, Inc.?
The price to book ratio of Hologic, Inc. is 3.8019.
What is Hologic, Inc.'s EBITDA?
Hologic, Inc.'s EBITDA is 1673.2.
What is the 50-day moving average of Hologic, Inc.?
The 50-day moving average of Hologic, Inc. is 80.8718.